26 Apr Wisconsin State Journal: $2 million investment boosts coffers of Imbed Biosciences
Imbed Biosciences says its wound-healing product is being used at five hospitals and more than 20 veterinary clinics, and a new investment will let the young Fitchburg company expand sales nationwide.
Imbed’s MicroLyte Ag Matrix is a patented, ultra-thin film coated with silver nanoparticles that stick to the surface of a wound.
More than 1,000 patients with chronic wounds — including those from surgery, burns, trauma wounds and diabetic ulcers — have been treated with the film in the past year, CEO and co-founder Ankit Agarwal said.
“It kills the bacteria that was hidden in deep wound tissue … and allows the body to regain its normal healing powers,” Agarwal said.
A clinical trial at Mission Health’s hospital in Asheville, North Carolina, showed that of 32 patients whose wounds had not healed in more than six months, more than 90% had some healing with Microlyte Ag after 12 weeks. On average, 75% of their wounds were closed.
Read the full Wisconsin State Journal article here.